Journal of Medicinal Chemistry p. 1452 - 1465 (2015)
Update date:2022-08-17
Topics:
Wu, Chien-Huang
Wang, Chuan-Jen
Chang, Chun-Ping
Cheng, Yung-Chi
Song, Jen-Shin
Jan, Jiing-Jyh
Chou, Ming-Chen
Ke, Yi-Yu
Ma, Jing
Wong, Ying-Chieh
Hsieh, Tsung-Chih
Tien, Yun-Chen
Gullen, Elizabeth A.
Lo, Chen-Fu
Cheng, Chia-Yi
Liu, Yu-Wei
Sadani, Amit A.
Tsai, Chia-Hua
Hsieh, Hsin-Pang
Tsou, Lun K.
Shia, Kak-Shan
Motivated by the pivotal role of CXCR4 as an HIV entry co-receptor, we herein report a de novo hit-to-lead effort on the identification of subnanomolar purine-based CXCR4 antagonists against HIV-1 infection. Compound 24, with an EC50 of 0.5 nM against HIV-1 entry into host cells and an IC50 of 16.4 nM for inhibition of radioligand stromal-derived factor-1α (SDF-1α) binding to CXCR4, was also found to be highly selective against closely related chemokine receptors. We rationalized that compound 24 complementarily interacted with the critical CXCR4 residues that are essential for binding to HIV-1 gp120 V3 loop and subsequent viral entry. Compound 24 showed a 130-fold increase in anti-HIV activity compared to that of the marketed CXCR4 antagonist, AMD3100 (Plerixafor), whereas both compounds exhibited similar potency in mobilization of CXCR4+/CD34+ stem cells at a high dose. Our study offers insight into the design of anti-HIV therapeutics devoid of major interference with SDF-1α function.
View MoreZHEJIANG CHEMICAL INDUSTRY INSTITUTE TECHNOLOGY CO.,LTD
Contact:86-575-82730298
Address:shangyu
Jiangsu Jiuri Chemical Co.,Ltd.
Contact:+86-519-82118868
Address:Tianwang Town, Jurong City, Jiangsu Province, China
TAIXING BEST NEW MATERIALS CO., LTD
Contact:0523-87998158;
Address:No.18 Zhonggang Road,Taixing City ,Jiangsu , China
website:http://www.hope-chem.com
Contact:86-21-58090396-805
Address:Floor 4, Building 5, No.588 Tianxiong Road, Zhoupu International Medical Zone, ShangHai, China
Contact:+8618766299236
Address:ROOM808, BUILDING2,NO.230 SHEN ZHEN ROAD, LAOSHAN DISTRICT
Doi:10.3390/60300244
(2001)Doi:10.1016/j.tetasy.2008.11.015
(2009)Doi:10.1002/ejoc.200300059
(2003)Doi:10.1007/s10562-021-03581-0
(2021)Doi:10.3184/174751912X13379433093990
(2012)Doi:10.1007/s11172-016-1451-7
(2016)